+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Spondyloarthritis Drug"

Axial Spondyloarthritis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Axial Spondyloarthritis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • July 2024
  • 231 Pages
  • Global
From
Axial Spondyloarthritis Market - A Global and Country Analysis: Focus on Commercialized Therapies, Potential Pipeline Products, Indication, and Country - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

Axial Spondyloarthritis Market - A Global and Country Analysis: Focus on Commercialized Therapies, Potential Pipeline Products, Indication, and Country - Analysis and Forecast, 2022-2032

  • Report
  • May 2022
  • 196 Pages
  • Global
From
Axial Spondyloarthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Axial Spondyloarthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 83 Pages
  • Global
From
Axial Spondyloarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Axial Spondyloarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 145 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Spondyloarthritis Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for chronic inflammatory diseases. Spondyloarthritis is a type of inflammatory arthritis that affects the spine and other joints, and is characterized by pain, stiffness, and swelling. Common treatments for spondyloarthritis include non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), and biologic drugs. NSAIDs are used to reduce pain and inflammation, while DMARDs and biologics are used to slow the progression of the disease. Some companies in the Spondyloarthritis Drug market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Novartis, Pfizer, and UCB. Show Less Read more